Skip to main content
. 2017 May 2;8(31):51037–51049. doi: 10.18632/oncotarget.17558

Figure 1. Design of Fc heterodimer.

Figure 1

(A) A schematic of human IgG1. (B) The structure of CH3 domains of wild-type Fc (PDB: 3AVE). Key residues involved in CH3-CH3 interface are showed as sticks. Green, CH3A; cyan, CH3B. (C) Fc heterodimer engineering based on the knob-hole strategy (KiH). (D) Knob (A) and hole (B) chain formation was analyzed by non-reducing SDS-PAGE. The yield of Fc heterodimer was assessed by densitometry analysis and shown in C.